Thermo Fisher Scientific has announced a strategic collaboration with SHL Medical, a provider of advanced drug delivery systems, alongside an expansion of sterile fill-finish and autoinjector final assembly capacity at its Ridgefield, NJ site.
At this year’s DCAT Week, Olon is outlining its 2026 development plan, aimed at expanding capabilities across its global network, including the United States, India, Italy, and France, through targeted investments and infrastructure upgrades.
Wilmington PharmaTech has announced a $50 million expansion of its Delaware campus to more than double its current API reactor capacity, supporting growing demand for high-quality, US-based manufacturing.
Clariant is expanding its Clear Lake site to include excipient GMP-compliant manufacturing of pharmaceutical-grade polyethylene glycol (PEG) excipients, aiming to improve their availability and reliability for North American customers.
Europa Biosite has announced a new strategic distribution partnership with Quantoom Biosciences, a manufacturer of innovative mRNA technologies for global healthcare advancement supporting next generation vaccines and therapeutics.
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI Environmental Solutions.
Axplora has announced a major milestone in its $60 million investment programme in highly potent API (HPAPI) manufacturing at its Farmabios site in Gropello Cairoli.
SGD Pharma has announced a strategic Franco-American OEM collaboration with Prince Sterilization Services, to validate Ready-to-Use (RTU) Type I glass primary packaging solutions serving the North American market.
Trenchant BioSystems and Invetech have announced that they have entered into a strategic alliance. The alliance will collaborate on the continued development of Trenchant’s fully automated AutoCell Platform, intended for future commercialisation.
Veeva Systems has acquired Ostro, a brand engagement platform for life sciences that gives patients and doctors immediate, compliant answers through an AI-driven chat experience.
Neuland Laboratories will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with further capacity expansions planned as client demand increases.
